Rani Therapeutics Holdings Inc Cl A (RANI) Stock Price, Quote & News

Company Profile

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes...

Industry: Biotechnology

Sector: Healthcare

Phone: 408 457 3700

Website: www.ranitherapeutics.com

Address:

2051 Ringwood Avenue, San Jose, United States

Spacey30 Jul. 3 at 11:08 AM

$RANI was added to the Russel Microcap Growth, the broader Russel Microcap Index, and the Russel 3000E Growth Index on 6/30. Funds that benchmark against those indices will now need to buy RANI shares.

0 · Reply

Spacey30 Jul. 3 at 11:01 AM

$RANI 👀 announce the start of the human trials already

0 · Reply

Beck1 Jun. 28 at 2:41 PM

$RANI

0 · Reply

Spacey30 Jun. 28 at 12:02 AM

$RANI dark horse projection, I give this an 85% chance to break .90 within 45 days. If it doesn’t I will eat my hat

0 · Reply

mikeymmike Jun. 26 at 6:08 PM

$RANI $10K bet on this. Either going to zero or a nice pop and payoff.

0 · Reply

BinaryLogic Jun. 25 at 10:57 AM

$RANI Double Bottom, Oversold on the 1YR Daily and 3YR Weekly charts. Granted-the balance sheet will require work and I do not even pretend that an equity issuance and RSS will not be required in the future. That said-there is reasonable opportunity here for a reversal, however transient of 25-50% (IMO). $0.7-0.8 resistance.

0 · Reply

smmajmoney Jun. 24 at 11:19 AM

$RANI anyone have and can share timeframe of the approval of the pill form they have in the pipeline. Do they have enough cash to get to the approval

1 · Reply

PUMPIT613 Jun. 19 at 2:38 AM

$RANI Let’s Go!!!!

0 · Reply

LifesGood Jun. 15 at 11:07 PM

$RANI

0 · Reply

Letsinvest2024 Jun. 13 at 9:53 PM

$RANI anybody here?

0 · Reply

Rani Therapeutics Announces Research Agreement with Chugai

May 13, 2025, 4:05 PM EDT - 7 weeks ago

Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update

Mar 31, 2025, 7:15 PM EDT - 3 months ago

Rani Therapeutics Holdings, Inc. (RANI) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 4:05 PM EDT - 3 months ago

Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update

Mar 26, 2025, 4:05 PM EDT - 3 months ago

Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102

Mar 25, 2025, 6:00 PM EDT - 3 months ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results

Oct 15, 2024, 8:30 AM EDT - 9 months ago

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants

Oct 8, 2024, 4:05 PM EDT - 9 months ago

Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 3, 2024, 4:05 PM EDT - 10 months ago

Rani Therapeutics to Participate in September Investor Conferences

Aug 6, 2024, 4:05 PM EDT - 11 months ago

Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update

Jul 29, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics to Participate in August Investor Conferences

Jul 22, 2024, 8:30 AM EDT - 1 year ago

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering

Jun 24, 2024, 7:00 AM EDT - 1 year ago

Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment

May 14, 2024, 8:00 AM EDT - 1 year ago

Rani Therapeutics to Participate in May Investor Conferences

May 9, 2024, 8:00 AM EDT - 1 year ago

Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024

May 6, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update

Mar 20, 2024, 7:05 PM EDT - 1 year ago

Rani Therapeutics Holdings, Inc. (RANI) Q4 2023 Earnings Call Transcript

Mar 20, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update

Mar 15, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

Dec 14, 2023, 8:00 AM EST - 1 year ago

Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist

Nov 8, 2023, 4:05 PM EST - 1 year ago

Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update

Oct 19, 2023, 4:05 PM EDT - 1 year ago

Rani Therapeutics Announces Successful Oral Delivery of Monoclonal Antibody via High-Capacity Pill in Preclinical Study

Oct 12, 2023, 4:05 PM EDT - 1 year ago

Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research

Sep 19, 2023, 6:36 AM EDT - 1 year ago

Rani Therapeutics: Excellent Technology But Major Risks Ahead

Sep 18, 2023, 8:00 AM EDT - 1 year ago

Rani Therapeutics Initiates Phase 1 Study of RT-111 (RaniPill® Containing Ustekinumab Biosimilar, CT-P43)

Sep 7, 2023, 4:05 PM EDT - 1 year ago

Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical Studies

Aug 11, 2023, 4:05 PM EDT - 2 years ago

Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update

Jun 21, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics' Presentation On Oral Delivery of PTH for Osteoporosis Named Presidential Poster Competition Winner at ENDO 2023 Annual Conference

Jun 8, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics Announces Acceptance of Late-Breaking Abstract of Oral Delivery of GLP-1 Agonist at the American Diabetes Association Annual Conference

Jun 5, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105

Jun 1, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics to Present at the Jefferies Healthcare Conference

May 31, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics Announces Acceptance of Three Abstracts for Presentation at ENDO 2023 Annual Conference

May 24, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics Appoints Kate McKinley as Chief Business Officer

May 10, 2023, 4:05 PM EDT - 2 years ago

Rani Therapeutics Reports First Quarter 2023 Financial Results; Provides Corporate Update

May 5, 2023, 5:33 PM EDT - 2 years ago

Rani Therapeutics: Novel Drug Delivery System, Under-Covered And Early Stage

Apr 11, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference

Mar 22, 2023, 6:43 PM EDT - 2 years ago

Rani Therapeutics Holdings, Inc. (RANI) Q4 2022 Earnings Call Transcript

Mar 22, 2023, 4:05 PM EDT - 2 years ago

Rani Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Corporate Update

Mar 16, 2023, 4:05 PM EDT - 2 years ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates

Jan 9, 2023, 8:30 AM EST - 2 years ago

Celltrion and Rani Therapeutics Partner on Development of Oral Monoclonal Antibody Treatment

Jan 5, 2023, 4:05 PM EST - 2 years ago

Rani Therapeutics Receives Feedback from Pre-IND Meeting with FDA; Provides Pipeline Update

Dec 6, 2022, 4:05 PM EST - 2 years ago

Rani Therapeutics Announces Repeat-Dose Topline Results from RT-102 Phase 1 Study

Nov 9, 2022, 4:05 PM EST - 2 years ago

Rani Therapeutics to Present at the Stifel Healthcare Conference

Oct 24, 2022, 8:30 AM EDT - 2 years ago

Rani Therapeutics Announces New RT-111 Development Program and Provides Corporate Update

Sep 6, 2022, 4:05 PM EDT - 3 years ago

Rani Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Aug 11, 2022, 11:47 PM EDT - 3 years ago

Rani Therapeutics Announces Termination of Public Offering of Class A Common Stock

Aug 10, 2022, 5:28 PM EDT - 3 years ago

Rani Therapeutics Announces Proposed Public Offering of Class A Common Stock

Aug 10, 2022, 4:28 PM EDT - 3 years ago

Rani Therapeutics Reports Second Quarter 2022 Financial Results; Provides Corporate Update

Aug 10, 2022, 4:23 PM EDT - 3 years ago

Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of RT-102 in Osteoporosis

Spacey30 Jul. 3 at 11:08 AM

0 · Reply

Spacey30 Jul. 3 at 11:01 AM

$RANI 👀 announce the start of the human trials already

0 · Reply

Beck1 Jun. 28 at 2:41 PM

$RANI

0 · Reply

Spacey30 Jun. 28 at 12:02 AM

$RANI dark horse projection, I give this an 85% chance to break .90 within 45 days. If it doesn’t I will eat my hat

0 · Reply

mikeymmike Jun. 26 at 6:08 PM

$RANI $10K bet on this. Either going to zero or a nice pop and payoff.

0 · Reply

BinaryLogic Jun. 25 at 10:57 AM

0 · Reply

smmajmoney Jun. 24 at 11:19 AM

$RANI anyone have and can share timeframe of the approval of the pill form they have in the pipeline. Do they have enough cash to get to the approval

1 · Reply

PUMPIT613 Jun. 19 at 2:38 AM

$RANI Let’s Go!!!!

0 · Reply

LifesGood Jun. 15 at 11:07 PM

$RANI

0 · Reply

Letsinvest2024 Jun. 13 at 9:53 PM

$RANI anybody here?

0 · Reply

Spacey30 Jun. 10 at 4:42 PM

$RANI somebody keeps trying to sell blocks of 20,000 shares at .61 🤔 who trying to exit?

0 · Reply

HITBC Jun. 10 at 3:42 PM

$TGE $MLGO $MFI LOADED THE FING BOAT BABY IN 100k each!!! LETS RIDE $GME $DJT $MARA $LAES $WKEY $TRAW $RANI $IREN $HOLO $FFAI

0 · Reply

Spacey30 Jun. 10 at 1:28 PM

$RANI is about to challenge SpaceX and Blue Origin because it’s going to start its ascent to the moon

0 · Reply

RichT844 Jun. 10 at 11:37 AM

$RANI looking at the history of analyst predictions, they 600% over current price and keep getting modified downward when they start to get around 1000% over. Analysts dont know anything!

0 · Reply

LilyR Jun. 9 at 7:33 PM

$RANI small position here, 4020 shares.

0 · Reply

BinaryLogic Jun. 9 at 12:55 AM

$RANI Oversold on the 1YR Daily and 3YR Weekly and I am watching for a double bottom at/around $0.46 to add. 50-100% upside from this level (IMO), as I have highlighted previously. I mentioned the same for $TRAW and $RYVL, and each one traded up 250-400% last week, however transient.

0 · Reply

DougieFreshPicks Jun. 5 at 11:48 PM

$RANI you got it 👍

0 · Reply

Letsinvest2024 Jun. 4 at 7:16 AM

$RANI $5 in a year

0 · Reply

Whiskey1679 Jun. 3 at 11:52 AM

$TOVX $SISI $EONR Premarket Gappers: $NAK $RANI

0 · Reply

Letsinvest2024 May. 30 at 8:12 PM

$SMMT another typical biotech $RANI $BLUE $TPST $NTLA

0 · Reply

Big123 May. 30 at 1:21 PM

$RANI

0 · Reply

CallMeMyBeer May. 30 at 1:31 AM

$RANI Investors gotta question why this company is partnered with a bunch of no names with no upfront pays. Big arse pharma aint interested. This is just dumb little science experiment! Anddd Employees trying to get paid as long as possible to tinker and having happy hour after.💩💩💩💩💩💩💩💩easy money for the cceo. DILUTION GALOREEEE

0 · Reply

Market Cap	30.78M
Revenue (ttm)	1.03M
Net Income (ttm)	-30.02M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-2,914.56%
Debt to Equity Ratio	-3.91

Volume	112,600
Avg Vol	526,256
Day's Range	N/A - N/A
Shares Out	57.48M
Stochastic %K	42%
Beta	-0.02
Analysts	Strong Sell
Price Target	$8.71